The DOI matches its Crossref record; 85 of the 85 references it cites were found in a registry or an index; 3 of the 173 sources its claims cite were checked for support.
In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp.
Open accessAbstract
The significance of polymicrobial infections is increasingly being recognized especially in a biofilm context wherein multiple bacterial species – including both potential pathogens and members of the commensal flora – communicate, cooperate and compete with each other. Two important bacterial pathogens that have developed a complex network of evasion, counter-inhibition and subjugation in their battle for space and nutrients are Pseudomonas aeruginosa and Staphylococcus aureus. Their strain- and environment-specific interactions, for instance in the cystic fibrosis lung or in wound infections, show severe competition that is generally linked to worse patient outcomes. For instance, the extracellular factors secreted by P. aeruginosa have been shown to subjugate S. aureus to persist as small colony variants. On the other hand, data also exist where S. aureus inhibits biofilm formation by P. aeruginosa but also protects the pathogen by inhibiting its phagocytosis. Interestingly, such interspecies interactions differ between the planktonic and biofilm phenotype, with the extracellular matrix components of the latter likely being a key, and largely underexplored, influence.This review attempts to understand the complex relationship between P. aeruginosa and Staphylococcus spp., focusing on S. aureus, that not only is interesting from the bacterial evolution point of view, but also has important consequences for our understanding of the disease pathogenesis for better patient management.
Overview
CoChat Summary
TL;DR
This review synthesizes in vivo and in vitro evidence on interactions between Pseudomonas aeruginosa and Staphylococcus spp., focusing on S. aureus, in biofilm and planktonic contexts. It describes a balance between P. aeruginosa antagonism—often via quorum-sensing-regulated factors such as HQNO, pyocyanin, LasA, rhamnolipids, and AHLs—and S. aureus survival strategies including SCV formation, SpA binding, and quorum quenching, with co-infection generally linked to worse outcomes.
Key findings
- Co-occurrence of P. aeruginosa and S. aureus in CF and chronic wounds is linked to worse outcomes: additive disease severity and increased lung inflammation/damage; MRSA is associated with worse lung function only in combination with P. aeruginosa. In a rabbit ear wound model, mixed infection increased IL-1β and TNF-α and reached equilibrium after 12 days with P. aeruginosa dominant; in a mouse chronic wound model, a four-species biofilm delayed healing only at 8 days post-infection and showed increased antimicrobial tolerance.
- P. aeruginosa produces multiple anti-staphylococcal molecules: HQNO and pyocyanin inhibit oxidative respiration and select for the SCV phenotype; LasA protease/staphylolysin lyses S. aureus; rhamnolipids and cis-2-decenoic acid induce biofilm dispersal and inhibit adhesion; long-chain AHLs (C8–C14, with C12 and C14 most effective) inhibit S. aureus growth and reduce sarA/agr function.
- S. aureus counter-strategies include the SigB-dependent SCV switch, which increases aminoglycoside resistance, biofilm formation, and intracellular survival; secreted protein A (SpA) binds Psl and type IV pili and protects P. aeruginosa from phagocytosis; yayurea A and B from the S. intermedius group quorum-quench Gram-negative bacteria; and CydAB variants in non-pathogenic staphylococci confer resistance to pyocyanin.
- Host/commensal molecules modulate virulence: AI-2 upregulates P. aeruginosa lasB, rhlA, exoT/exoS/exoY, and phzA1/phzA2; GlcNAc enhances PQS and virulence; D-ribose treatment significantly decreased biomass and lowered rat mortality in a dual-species ventilation model.
Methods
- Narrative review; no primary experiments. It synthesizes in vivo human/animal observations and in vitro studies on P. aeruginosa and Staphylococcus spp., primarily S. aureus.
- Main analysis is a qualitative synthesis of cited literature, organized by in vivo outcomes, P. aeruginosa virulence factors, S. aureus survival/SCV biology, dual-species biofilms, and other staphylococci. No systematic search, meta-analysis, or primary sample is described.
Limitations
- The paper states that interactions are strain- and environment-specific, that extracellular matrix components are largely underexplored, and that discrepancies between studies (e.g., Psl/S. aureus co-culture results, pigment production) indicate the importance of co-evolution and adaptation; further studies are awaited.
- Evident from the text: as a narrative review, it lacks a described systematic search or quality appraisal and relies on heterogeneous models, strains, and conditions, limiting generalizability.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
2 Valid · 0 Not valid · 127 Not checked · 30 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Chronic wounds are another example of biofilm-related infections wherein co-presence of P. aeruginosa and S. aureus has been shown to result in delayed wound healing compared to single species infections (Dalton et al., 2011; Seth et al., 2012; Pastar et al., 2013).”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
What the sources say
- Partly supportedcites Dalton et al., 2011 sourceExperimental — accuracy not yet measured
In the Results section 'Examining the ability of polymicrobial infections to promote wound chronicity', Dalton et al. do report that wounds with polymicrobial infections closed more slowly than monospecies infections, significant only at the 8-day time point (p<0.05) — but the comparison is a four-species biofilm (S. aureus, P. aeruginosa, E. faecalis, F. magna) versus P. aeruginosa alone in murine surgical excision wounds, not a P. aeruginosa/S. aureus co-presence comparison and not human chronic wounds. The same passage explicitly concludes that 'the mere presence of multiple species in a wound do not necessarily delay wound closure,' and the Discussion frames the finding as limited to one time point, so the claim's unqualified two-species causal statement overstates and re-specifies what this source shows. Part of what is attributed (delayed closure with polymicrobial, Pa-containing infections relative to single-species) is in the paper; the dual-species Pa+Sa attribution, the chronic-wound setting, and the general 'results in' framing are not. (LLM, conf=0.78)
- Not checked yetcites Seth et al., 2012 source
Checked before — its earlier verdict is held back until a new check runs.
- Partly supportedcites Pastar et al., 2013 sourceExperimental — accuracy not yet measured
The Results section ('Mixed-species Infection Delays Epithelialization through Suppression of KGF1') and the Abstract state that simultaneous USA300 + P. aeruginosa infection significantly impaired epithelialization relative to single-species biofilms (day 2 rates 35% vs 42% and 57%, and 74% in uninfected controls), so the comparative core of the claim is supported. However, this was demonstrated in an acute porcine partial-thickness wound model, not in chronic wounds; the paper only notes in the Introduction/Discussion that chronic non-healing wounds are polymicrobial and that S. aureus and P. aeruginosa are prevalent there. The setting qualifier 'in chronic wounds' is therefore not supported by this source. (LLM, conf=0.80)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, polymicrobial infections showed increased antimicrobial tolerance compared to single species infection with P. aeruginosa in this study (Dalton et al., 2011).”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
What the sources say
- Supportedcites Dalton et al., 2011 source
The Results section 'Measuring the antimicrobial tolerance of mono versus polymicrobial infections in situ' states that higher numbers of bacteria remained viable after bleach (2.3-fold) and gentamicin (3-fold) treatment in the polymicrobial infection group than in the P. aeruginosa monospecies group (Fig. 7A), and the Discussion repeats 'a higher level of antimicrobial tolerance from the bacteria making up the polymicrobial infection'. The Materials and Methods ('Chronically-wounded mouse model', 'Determining antimicrobial tolerance') confirm this was done in the murine chronic excision wound model, so population, comparator and direction of effect all match the paraphrase. (LLM, conf=0.93)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
None of the sources cited for this claim have been checked yet.
In the paper
“An increasing incidence of P. aeruginosa with age has been shown to coincide with a decreasing S. aureus incidence in CF patients (Harrison, 2007; Cystic Fibrosis Foundation, 2014), data that primarily indicates an antagonistic relationship between the two pathogens.”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
What the sources say
- Not checked yetcites Harrison, 2007 source
- Not matchedcites Cystic Fibrosis Foundation, 2014
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Nonetheless, recent studies have also co-isolated P. aeruginosa and Gram-positive bacteria, including S. aureus, from the same infection site where increased virulence and/or antibiotic resistance is described (Duan et al., 2003; Kirketerp-Moller et al., 2008; Fazli et al., 2009; Dalton et al., 2011; Korgaonkar et al., 2013).”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Introduction
What the sources say
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“An increasing incidence of P. aeruginosa with age has been shown to coincide with a decreasing S. aureus incidence in CF patients (Harrison, 2007; Cystic Fibrosis Foundation, 2014), data that primarily indicates an antagonistic relationship between the two pathogens.”
§ In vivo and In vitro Interactions between Pseudomonas aeruginosa and Staphylococcus spp. > Co-occurrence of P. aeruginosa and S. aureus in vivo is linked to worse disease outcomes
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
79 more claims
Create a free account to see all 159 claims and to verify the 164 references still open.
- It may state two separate claims as one. 70
- Probably not a substantial claim. 8
Citations
Cites
Flemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Bacterial biofilms: from the Natural environment to infectious diseases
Hall-Stoodley, L., Costerton, J. W., & Stoodley, P. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro821 · Cited by 7,143
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Proctor, R. A., von Eiff, C., Kahl, B. C., Becker, K., McNamara, P., Herrmann, M., & Peters, G. (2006) · Nature Reviews Microbiology · doi:10.1038/nrmicro1384 · Cited by 1,175
What drives bacteria to produce a biofilm?
Jefferson, K. K. (2004) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2004.06.005 · Cited by 1,059
The type III secretion system of Pseudomonas aeruginosa: infection by injection
Hauser, A. R. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2199 · Cited by 968
agr-Mediated Dispersal of Staphylococcus aureus Biofilms
Boles, B. R., & Horswill, A. R. (2008) · PLoS Pathogens · doi:10.1371/journal.ppat.1000052 · Cited by 963
Williams, P., & Cámara, M. (2009) · Current Opinion in Microbiology · doi:10.1016/j.mib.2009.01.005 · Cited by 793
The Multiple Signaling Systems Regulating Virulence in Pseudomonas aeruginosa
Nadal Jimenez, P., Koch, G., Thompson, J. A., Xavier, K. B., Cool, R. H., & Quax, W. J. (2012) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.05007-11 · Cited by 736
Quorum Sensing and Bacterial Social Interactions in Biofilms
Li, Y.-H., & Tian, X. (2012) · Sensors · doi:10.3390/s120302519 · Cited by 694
Cited by
Items 201–289 of 289
Mitra, S., Padhi, T. R., Basu, S., Priyadarshini, S. R., & Sharma, S. (2018) · International Ophthalmology · doi:10.1007/s10792-018-1019-7 · Cited by 4
Živković, V., Kurevija, T., Drenjančević, I. H., Bogdan, M., Talapko, J., & Drenjančević, D. (2018) · Southeastern European medical journal · doi:10.26332/seemedj.v2i1.69 · Cited by 4
Hydrogel Dressings as Insulin Delivery Systems for Diabetic Wounds
Kłapcia, A., & Domalik-Pyzik, P. (2025) · Frontiers in Bioscience-Elite · doi:10.31083/fbe26446 · Cited by 4
Milić, J., Škrlec, I., Vranješ, I. M., Matić, M., Sertić, D., & Heffer, M. (2018) · Southeastern European medical journal · doi:10.26332/seemedj.v2i1.62 · Cited by 7
Role of biofilm in host–pathogen interaction
Sharma, S., Sharma, S., & Tiwari, V. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-88480-8.00016-9 · Cited by 3
Mixed bacterial-viral lung infections in patients with cystic fibrosis
Burmistrov, E. M., Геннадьевич, К. К., Avetisyan, L. R., Siyanova, E. A., Medvedeva, O. S., Tselikina, E. G., Polyakov, N. B., Solovyev, A. I., Voronkova, A. Y., Kondratyeva, E., et al. (2023) · PULMONOLOGIYA · doi:10.18093/0869-0189-2023-33-4-488-496 · Cited by 3
Anti‐Biofilm and Anti‐Virulence Potential of 2‐Amino‐1,3,4‐Thiadiazole Derivatives
Saravanan, K., Venugopal, S., Murugesan, R., & Ramasamy, M. (2024) · ChemistrySelect · doi:10.1002/slct.202400379 · Cited by 3
de Oliveira, B. T. M., de Lima, K. Y. G., Arruda, R. R. A., & Vasconcelos, U. (2021) · Brazilian Journal of Development · doi:10.34117/bjdv7n10-227 · Cited by 3
Schwyter, L., Niggli, S., Zajac, N., Poveda, L., Wolski, W., Panse, C., Schlapbach, R., Kümmerli, R., & Grossmann, J. (2025) · mSystems · doi:10.1128/msystems.00262-25 · Cited by 2
Admella, J., Alcàcer‐Almansa, J., Julián, E., & Torrents, E. (2025) · iScience · doi:10.1016/j.isci.2025.113620 · Cited by 2
Subramanian, A. (2025) · Indian Journal of Microbiology · doi:10.1007/s12088-025-01526-4 · Cited by 2
Halimi, A., Tani, Z. Z. B. A., & Aissaoui, M. (2026) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2026.117251 · Cited by 2
Crivello, G., Pezzuto, M. F., Armanetti, P., Cassino, C., Ceresa, C., Fracchia, L., Catarinicchia, C., Villani, S., Alifano, P., Demitri, C., et al. (2026) · Macromolecular Bioscience · doi:10.1002/mabi.202500532 · Cited by 2
Exploring microorganism–host interactions: Emerging organoid models and analytical approaches
Shi, Y., Xu, M., Huang, Y., Qu, J., Liao, S., Liu, Y., & Li, L. (2026) · mLife · doi:10.1002/mlf2.70053 · Cited by 2
Bottacin, G., Raach, B., Fröhlich, L., Künnecke, J., Kaczmarczyk, A., Tejada-Arranz, A., Ugolini, G. S., Stocker, R., Jenal, U., Bumann, D., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2604163123 · Cited by 2
Bényei, É. B., Nazeer, R. R., Askenasy, I., Mancini, L., Ho, P.-M., Sivarajan, G. A. C., Swain, J. E. V., & Welch, M. (2024) · Advances in microbial physiology/Advances in Microbial Physiology · doi:10.1016/bs.ampbs.2024.04.002 · Cited by 2
A fluorescence-based protocol to monitor bacterial antagonism
Luu, J. M., Crisan, C. V., Pettis, M. L., Ramos, A., Read, T. D., & Goldberg, J. B. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.03183-24 · Cited by 2
Cano, S., Clari, M. Á., Bolado, D., Carbonell, N., & Navarro, D. (2025) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2025.117029 · Cited by 2
Pajon, C., Fortoul, M. C., Diaz-Tang, G., Meneses, E. M., Kalifa, A. R., Sevy, E., Mariah, T., Toscan, B., Marcelin, M., Hernandez, D. M., et al. (2023) · eLife · doi:10.7554/elife.83664.sa2 · Cited by 2
Characteristics of soil origin Pseudomonas batumici Koz11 isolated from a remote island in Japan
Zuo, H., Morimoto, Y., Muroi, K., & Baba, T. (2024) · Access Microbiology · doi:10.1099/acmi.0.000799.v3 · Cited by 1
Darwitz, B. P., Lifschin, Z. J., Miller, C. M., Genito, C. J., Gossett, C. A., Augustine, K. E., & Thurlow, L. R. (2025) · Journal of Bacteriology · doi:10.1128/jb.00333-25 · Cited by 1
Mazzolini, R., Garrido, V., Gómez, A.-C., Collantes, M., Grilló, M. J., Piñero‐Lambea, C., Gibert, I., Yero, D., & Lluch‐Senar, M. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00835-2 · Cited by 1
Helal, Z., Elshaer, S. L., El‐Mowafy, M., & Habib, E. E. (2026) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-025-00843-2 · Cited by 1
Das, S., Roy, R., Malik, M., Paul, P., Chakraborty, P., Chatterjee, S., Maiti, D., & Tribedi, P. (2026) · Biofouling · doi:10.1080/08927014.2026.2630947 · Cited by 1
Blue light-activated berberine–gentamicin combination breaks down biofilms in diabetic foot ulcers
Gonçalves, A. S. C., Leitão, M. M., Simões, M. V., & Borges, A. (2026) · Journal of Materials Chemistry B · doi:10.1039/d6tb00081a · Cited by 2
Guerra, N. D. S., Rodrigues, B. Á., Loureiro, I. P., Maboni, L. J., & Zimmer, K. R. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108604 · Cited by 1
Briaud, P., Bastien, S., Camus, L., Boyadjian, M., Reix, P., Mainguy, C., Vandenesch, F., Doléans-Jordheim, A., & Moreau, K. (2020) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(20)30466-5 · Cited by 1
Lysis‐Hi‐C as a method to study polymicrobial communities and eDNA
Hill, B. M., Bisht, K., Atkins, G. R., Gomez, A. A., Rumbaugh, K. P., Wakeman, C. A., & Brown, A. M. V. (2021) · Molecular Ecology Resources · doi:10.1111/1755-0998.13535 · Cited by 1
The Clinical Significance ofStaphylococcus aureusSmall Colony Variants
Keim, K. C., George, I. K., Reynolds, L., & Smith, A. C. (2021) · American Society for Clinical Laboratory Science · doi:10.29074/ascls.2020002691 · Cited by 1
Death of a bacterium: exploring the inhibition of Staphylococcus aureus by Burkholderia cenocepacia.
Brandt, T. (2022) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3990 · Cited by 1
Giedraitis, E., Neve, R. L., & Phelan, V. V. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.06.611695 · Cited by 1
Towards New Topical Treatments For Bacterial Infection
Lee, V. E. (2018) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Millette, G. (2019) · Knowledge UdeS (Institutional Deposit of the University of Sherbrooke)
The effect of Stenotrophomonas maltophilia on Gram-negative cystic fibrosis pathogens.
Stewart, J. (2019) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville)
Hill, M. N. (2019) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville)
Pedraz, L. (2020) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Briaud, P. (2019) · theses.fr (ABES) · doi:10.70675/5259f902zbd03z445ez9f9ez1318fa8cbb77 · Cited by 2
Investigation of Bacterial Interactions Using Lab on Chips
Nichele, L., Ninno, A. D., Gerardino, A., Bertani, F. R., Visaggio, D., Lucidi, M., Visca, P., Businaro, L., & Cincotti, G. (2020) · International Conference on Transparent Optical Networks · doi:10.1109/icton51198.2020.9203049
Do bacteria implicated in Ventilator-Associated Pneumonia adapt to antibiotic exposure?
Parkes, J. (2020) · University of Salford Institutional Repository (University of Salford)
Immunochemical diagnostic strategies based on Quorum Sensing
Cañete, M., & Enrique, J. (2021) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Arabestani, M. R., Alikhani, M. Y., Tahmasebi, H., & Dehbashi, S. (2020) · Research Square · doi:10.21203/rs.3.rs-44061/v1
Maželienė, Ž., Aleksandravičienė, A., Petrauskaitė, A., Viliušienė, I., & Šakienė, D. (2021) · Health Sciences · doi:10.35988/sm-hs.2021.233
Quorum sensing relationship analysis of microbial symbionts
Thirunavukkarasu, R., Pandi, P., Pushparaj, S., Subramanian, K., & Arokiarajan, M. S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99334-0.00031-1
Interspecies Interaction between Pseudomonas aeruginosa, Staphylococcus aureus and E. coli in vitro
Abdelwahab, I. A., Abozahra, R., Sultan, S. A., Abd-elaal, H. M., & Abdelhamid, S. M. (2023) · Journal of Pure and Applied Microbiology · doi:10.22207/jpam.17.1.39
Ersoy, G. Z., Ergüven, M., & Yıldız, M. (2023) · The Journal of Pediatric Research · doi:10.4274/jpr.galenos.2022.04207
D’ennemis à amants : la coopération trophique entre S. aureus et P. aeruginosa autour de l’acétoïne
Blanc, J., Cadot-Jet, N., & Deshayes, T. (2023) · médecine/sciences · doi:10.1051/medsci/2023044
El-Mahdy, A. M., & Mahran, Y. F. (2023) · The Egyptian Journal of Medical Microbiology · doi:10.21608/ejmm.2023.312957
Chronic infection: as an ecological model for emergence of the chronic obstructive pulmonary disease
Alekseev, D. V., Lyamin, A. V., & Kaiumov, K. A. (2023) · Novel Research in Microbiology Journal · doi:10.21608/nrmj.2023.319451
Complex ecological approach to cystic fibrosis respiratory infections
Alekseev, D. V., Lyamin, A. V., & Kaiumov, K. A. (2023) · Novel Research in Microbiology Journal · doi:10.21608/nrmj.2023.327188
Giesel, H., Brown, T., Halabi, S., Jansen, B., & Bost, A. (2025) · Spectrum · doi:10.29173/spectrum294
Aspirin‐Conjugated Cholic Acid Derivative Combats Polymicrobial Infections and Inflammation
Safwan, S. M., Mehta, D., Saini, V., Jain, D., Chourasiya, N. K., Arora, A., Khatol, S., Singh, M., Verma, V., & Bajaj, A. (2025) · ChemMedChem · doi:10.1002/cmdc.202500174
Nitric Oxide Tunes Secreted Metabolite Bioactivity
Lonergan, Z. R., Weisflog, S. L., Scurria, M., Li, J., Thalhammer, K. O., Gutiérrez, O., Conway, S. J., & Newman, D. K. (2026) · Molecular Microbiology · doi:10.1111/mmi.70083
c-di-GMP fine tunes the Pil-Chp system to control type IV pilus-mediated interspecies chemotaxis
Yarrington, K. D. (2024) · Iowa Research Online (The University of Iowa) · doi:10.25820/etd.007732
Ramos, A. S. F. D. A. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/xqve-sa13
Elucidating the mechanism of action of novel lactams on Pseudomonas aeruginosa
Pantalone, P. (2019) · Nottingham ePrints (University of Nottingham)
Grainha, T. (2023) · RepositóriUM (Universidade do Minho)
Marguč, S. (2024) · Repository of the University of Ljubljana (University of Ljubljana)
Landa Baila, G., Gordo, M. A., & Cantos, G. M. M. (2024) · Zaguan (Universidad de Zaragoza)
Zatout, A., Rachid, D., Dahah, H., Errahmen, M. H., Benkredda, F., & Ahmed, K.-L. (2019) · International Journal of Biosciences (IJB) · doi:10.12692/ijb/15.3.412-424
Zhang, B., Wang, X., Qi, X., Zhang, L., Pei, N., Tao, Z., & Liu, J. (2026) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlag023
Can commensals alter pathogen’s antibiotic resistance during co-culture?
Kingdon, A. D. H., Jordana‐Lluch, E., & Hardie, K. R. (2026) · Journal of Medical Microbiology · doi:10.1099/jmm.0.002126
Emergence de la résistance au linézolide chez les staphylocoques
Rouard, C. (2018) · theses.fr (ABES) · doi:10.70675/351eca54zf02bz4f43z8d77zf0279402be4f
Camus, L. (2020) · theses.fr (ABES) · doi:10.70675/ecddb701z1d6fz422fz86d0zc4e6a93d6a98 · Cited by 1
Trognon, J. (2022) · theses.fr (ABES) · doi:10.70675/f132b857zd772z4779z9422z76da46728122
Drivers and consequences of Staphylococcus aureus adaptation to the lung environment
Ding, X. (2023) · theses.fr (ABES) · doi:10.70675/573abae1zc747z4076z949bza2bdaea8b677
Vyšniauskaitė, R. (2021) · Lithuanian University of Health Sciences
Logic programming tools for metabolic fluxes analysis and biological applications
Mahout, M. (2023) · theses.fr (ABES) · doi:10.70675/a4f76dc9z54aaz4c4bza3aez5a23506df981 · Cited by 1
Pseudomonas aeruginosa deploys competitor-specific antagonistic strategiesPreprint
Chen, Z., Wingreen, N. S., & Gitai, Z. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.14.718318
Shabana, S., Buvabi, S. H., Nethravathi, H. B., Gunasekaran, B., & Rao, P. V. (2026) · Natural Resources for Human Health · doi:10.53365/nrfhh/217496
Hu, H., You, M., He, T., Yuan, L., Wang, F., Huang, Y., Zhu, H., Chen, R., Liu, S., Wei, W., et al. (2026) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-026-10825-3
Abdulsamad, M. A., Bardaa, S., Elleuch, M., Mathlouthi, N. E. H., & Ali, M. B. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1825173
Pan, D., Liu, R., Qiu, J., Wu, Z., Su, N., Shi, J., & Cheng, N. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03349-25
Fenn, S. J., Recker, M., & Massey, R. C. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-01112-6
MMed, X. S., Ramezanpour, M., Bouras, G., Barry, E. F., Psaltis, A. J., Wormald, P., & Vreugde, S. (2026) · International Forum of Allergy & Rhinology · doi:10.1002/alr.70228
Domblides, E. A., Chernukha, M. Y., Avetisyan, L. R., Kyian, T. A., Zhukhovitsky, V. G., Алексеевич, Г. В., & Kondratyeva, E. I. (2026) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2026.1.50-63
Williams, D. L., Falconer, R., Rothberg, D. L., López, M., Adams, J., Miller, A., Epperson, R. T., Kawaguchi, B., Garrett, C., Pasquina, P. F., et al. (2026) · Microorganisms · doi:10.3390/microorganisms14092062
Zhou, H., Liu, W., Peng, X., Li, M., He, Z., Liu, H., Yang, X., Guo, Z., 张文涛, Fu, W., et al. (2026) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2026.101222 · Cited by 1
Design of a multi-functional, nanoparticles-loaded supramolecular hydrogel to treat chronic wounds
Crivello, G. (2024) · PORTO@Iris
Ma'aitah, S., & AlAmairyin, B. (2026) · Journal of Basic and Applied Research in Biomedicine · doi:10.51152/jbarbiomed.v12i1.267
Bru, J.-L., Kasallis, S. J., Chang, R., Zhuo, Q., Nguyen, J., Pham, P., Warren, E., Whiteson, K., Høyland-Kroghsbo, N. M., Limoli, D. H., et al. (2023) · doi:10.3389/fcimb.2023.1245874.s005
Yarrington, K. D., Shendruk, T. N., & Limoli, D. H. (2024) · doi:10.1371/journal.pbio.3002488.r002
Jiang, K., Xu, Y., Yuan, B., Yue, Y., Zhao, M., Luo, R., Wu, H., Wang, L., Zhang, Y., Xiao, J., et al. (2022) · doi:10.3389/fmicb.2022.791802.s002
Metadata
- Authors
- Hotterbeekx, A., Kumar-Singh, S., Goossens, H., & Malhotra-Kumar, S.
- Affiliations
- University of Antwerp (BE)
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2017-04-03
- Volume
- 7
- Pages
- 106-106
- ISSN
- 2235-2988 (ISSN-L)
- PMC
- PMC5376567
- OpenAlex
- W2599504373
- Cited by
- 289
- References
- 85
- Citations by year
- 2026: 28 · 2025: 29 · 2024: 31 · 2023: 39 · 2022: 44 · 2021: 41 · 2020: 35 · 2019: 23 · 2018: 19
- FWCI
- 1.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Frontiers in Cellular and Infection Microbiology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- Funders
- Fonds Wetenschappelijk Onderzoek (G.0513.12)
- IMI (115737-2)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
- Health Sciences › Medicine › Microbiology (medical) › Infections and bacterial resistance
- Keywords
- Pseudomonas aeruginosa, Staphylococcus aureus, interspecies interactions, co-infection, biofilm, small colony variants, phagocytosis inhibition, extracellular matrix, cystic fibrosis lung infection, wound infection, bacterial competition, commensal microbiota
- MeSH terms
- Animals, Disease Models, Animal, Humans, Pseudomonas aeruginosa, Staphylococcus aureus, Microbial Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-15, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-15 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.